PFAS System Validation

RNS Number : 6053Y
MyCelx Technologies Corporation
14 May 2021
 

14 May 2021

 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

 

PFAS System Validation

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology experts, is pleased to announce validation and capacity upgrade of its PFAS system at an Australian Department of Defence location. 

 

This follows a successful deployment of the PFAS system by our Australian partner in 2018. The capacity upgrade contract was awarded as a consequence of the robust operating performance demonstrated over a two-year period, within budget, as well as allowing the customer to both support, improve and adhere to, its environmental goals.

 

PFAS (Perfluoroalkyl substances) remediation has been a key area of organic diversification for MYCELX and the Company is delighted with the progress made. This re-deployment is a step forward for the Company and has the potential to lead to further contract awards in due course. With the increasing awareness and legislation worldwide, the benefits of MYCELX's proprietary technology allows for efficient removal of toxic "forever" chemicals associated with adhesives and Teflon related products and has the potential to be a leading solution for PFAS remediation worldwide.

 

We look forward to updating shareholders further when the Company announces its 2020 Full Year Results the week commencing 24 May 2021.

 

Connie Mixon, CEO, said:

 

"This is an important contract as it proves that our PFAS system is cost effective, robust and reaffirms the rationale for our investment in this market since 2018."

 

For further information please contact:  

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

Tel: +1 888 306 6843

Celicourt

Mark Antelme

Jimmy Lea

 

Tel: +44 20 8434 2754

 

About RNS Reach announcements

 

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

Notes to Editors

 

Through its revolutionary oil-free water technology, MYCELX brings its customers material benefits in terms of performance enhancement, cost savings and significantly improved environmental footprints. Working beyond any ordinary filtration methods, MYCELX's proprietary technology achieves oil removal to less than one part per million.  MYCELX supports leading international customers across the oil & gas value chain, as well as other industrial users.  MYCELX also provides advanced air filtration technology for manufacturing and industrial facilities, effectively removing oil particles and biologicals to maintain continuous and safe air quality levels.

 

For more information, visit www.MYCELX.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAAJMPTMTJBBTB
UK 100

Latest directors dealings